We selected the physical interaction of MYC with NSD3 for validation, and uncovered a potential positive regulatory function for NSD3 in activating MYC, implicating the BRD4-NSD3-MYC pathway as a potential target for interrogating MYC-driven tumours. This evidence concerns the gene MYC and neoplasm.